Metis Global Partners LLC Acquires 1,013 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Metis Global Partners LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.3% in the 4th quarter, HoldingsChannel.com reports. The fund owned 17,140 shares of the medical equipment provider’s stock after purchasing an additional 1,013 shares during the quarter. Metis Global Partners LLC’s holdings in Intuitive Surgical were worth $8,946,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Williamson Legacy Group LLC boosted its stake in Intuitive Surgical by 8.5% in the 4th quarter. Williamson Legacy Group LLC now owns 1,193 shares of the medical equipment provider’s stock valued at $623,000 after purchasing an additional 93 shares during the period. Fisher Asset Management LLC boosted its stake in Intuitive Surgical by 1.8% in the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after purchasing an additional 86,488 shares during the period. Cobblestone Capital Advisors LLC NY boosted its stake in Intuitive Surgical by 4.3% in the 4th quarter. Cobblestone Capital Advisors LLC NY now owns 1,398 shares of the medical equipment provider’s stock valued at $730,000 after purchasing an additional 58 shares during the period. Maple Capital Management Inc. boosted its stake in Intuitive Surgical by 3.1% in the 4th quarter. Maple Capital Management Inc. now owns 39,643 shares of the medical equipment provider’s stock valued at $20,692,000 after purchasing an additional 1,181 shares during the period. Finally, SVB Wealth LLC bought a new stake in Intuitive Surgical in the 4th quarter valued at $12,717,000. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the sale, the executive vice president now owns 353 shares in the company, valued at $208,181.75. This trade represents a 53.61 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 8,077 shares of company stock worth $4,620,025 in the last 90 days. Insiders own 0.80% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Citigroup boosted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Truist Financial lifted their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Finally, Raymond James lifted their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Stock Up 1.7 %

Shares of ISRG stock opened at $573.15 on Friday. The firm has a market capitalization of $204.14 billion, a P/E ratio of 89.42, a P/E/G ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock’s fifty day simple moving average is $569.87 and its 200 day simple moving average is $528.64.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.